GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » EV-to-Revenue

Perseus Proteomics (TSE:4882) EV-to-Revenue : 26.87 (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Perseus Proteomics's enterprise value is 円2,585.77 Mil. Perseus Proteomics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円96.22 Mil. Therefore, Perseus Proteomics's EV-to-Revenue for today is 26.87.

The historical rank and industry rank for Perseus Proteomics's EV-to-Revenue or its related term are showing as below:

TSE:4882' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.05   Med: 19.48   Max: 150.31
Current: 26.88

During the past 6 years, the highest EV-to-Revenue of Perseus Proteomics was 150.31. The lowest was 2.05. And the median was 19.48.

TSE:4882's EV-to-Revenue is ranked worse than
93.18% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.42 vs TSE:4882: 26.88

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-21), Perseus Proteomics's stock price is 円356.00. Perseus Proteomics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円8.17. Therefore, Perseus Proteomics's PS Ratio for today is 43.56.


Perseus Proteomics EV-to-Revenue Historical Data

The historical data trend for Perseus Proteomics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics EV-to-Revenue Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial - - - 23.31 11.25

Perseus Proteomics Quarterly Data
Mar18 Mar19 Dec19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.69 11.25 13.80 37.01 58.69

Competitive Comparison of Perseus Proteomics's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Perseus Proteomics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perseus Proteomics's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perseus Proteomics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Perseus Proteomics's EV-to-Revenue falls into.



Perseus Proteomics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Perseus Proteomics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2585.765/96.218
=26.87

Perseus Proteomics's current Enterprise Value is 円2,585.77 Mil.
Perseus Proteomics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円96.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Perseus Proteomics  (TSE:4882) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Perseus Proteomics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=356.00/8.172
=43.56

Perseus Proteomics's share price for today is 円356.00.
Perseus Proteomics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円8.17.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Perseus Proteomics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Perseus Proteomics (TSE:4882) Business Description

Traded in Other Exchanges
N/A
Address
4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines